Overview of Dr. Sogani
Dr. Pramod Sogani is an urologist in New York, NY and is affiliated with Memorial Sloan-Kettering Cancer Center. He received his medical degree from M.G.M. Medical College and has been in practice 57 years. Dr. Sogani accepts several types of health insurance, listed below. He is one of 66 doctors at Memorial Sloan-Kettering Cancer Center who specialize in Urology. He has more than 100 publications and over 500 citings.
Education & Training New York Presbyterian Hospital (Cornell Campus) Residency, Urology, 1971 - 1973 George Washington University Residency, Urology, 1969 - 1971 New York University School of Medicine Residency, Urology, 1968 - 1969 The MetroHealth System/Case Western Reserve University Residency, Surgery, 1966 - 1968 M.G.M. Medical College Class of 1960 Certifications & Licensure CA State Medical License 1977 - Present NY State Medical License 1972 - 2024 NJ State Medical License 1972 - 2023 American Board of Urology Urology Awards, Honors, & Recognition Top Doctors: New York Metro Area Castle Connolly, 2002-2014 Fellow (FACS) American College of Surgeons Publications & Presentations PubMed
Legends in Urology v30I01.
Pramod C Sogani> ;The Canadian Journal of Urology. 2023 Feb 1
Harry Herr, Pramod Sogani, James Eastham> ;Journal of Surgical Oncology. 2022 Oct 1 92 citations
The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance.
Behfar Ehdaie, Emily Vertosick, Massimiliano Spaliviero, Anna Giallo-Uvino, Ying Taur, Maryellen O’Sullivan, Jennifer Livingston, Pramod C. Sogani, James A. Eastham, P...> ;The Journal of Urology. 2014 Mar 1 2 citations
Surgery for retroperitoneal relapse in the setting of a prior retroperitoneal lymph node dissection for germ cell tumor.
Geoffrey Gotto, Brett S. Carver, Pramod C. Sogani, Joel Sheinfeld> ;Indian Journal of Urology. 2010 Jan 1 6 citations
Reoperative Retroperitoneal Surgery
Joel Sheinfeld, Pramod C. Sogani> ;Urologic Clinics of North America. 2007 May 1
Androgen deprivation therapy for biochemical recurrence in patients with seminal vesicle invasion after radical prostatectomy.
Secin FP, Bianco FJ, Vickers AJ, Sogani P, Scher HI, Scardino PT> ;J. Clin. Oncol.. 2005-06-01 72 citations
Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma.
Michael Mullerad, Paul Russo, Dragan Golijanin, Hui N.I. Chen, Harold Tsai, S. Machele Donat, Bernard H. Bochner, Harry W. Herr, Joel Sheinfeld, Pramod C. Sogani, Mich...> ;The Journal of Urology. 2004 Dec 1 87 citations
Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection.
Jeffrey M. Holzbeierlein, Ernesto Lopez-Corona, Bernard H. Bochner, Harry W. Herr, S. Machele Donat, Paul Russo, Guido Dalbagni, Pramod C. Sogani> ;The Journal of Urology. 2004 Sep 1
Previous history of bladder cancer as a prognostic factor for patients diagnosed with transitional cell carcinoma of the upper urinary tract.
Mullerad M, Golijanin D, Chen HN, Donat S, Bochner B, Herr HW, Sogani PC, Russo P, Kattan MW, Dalbagni G> ;J. Clin. Oncol.. 2004-07-15 66 citations
Carcinoma in a bladder diverticulum: presentation and treatment outcome.
Dragan Golijanin, Ofer Yossepowitch, Stephen D.W. Beck, Pramod C. Sogani, Guido Dalbagni> ;The Journal of Urology. 2003 Nov 1 59 citations
Histology and clinical outcomes in patients with bilateral testicular germ cell tumors: the Memorial Sloan Kettering Cancer Center experience 1950 to 2001.
Jeffrey M. Holzbeierlein, Pramod C. Sogani, Joel Sheinfeld> ;The Journal of Urology. 2003 Jun 1 26 citations
Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder.
Guido Dalbagni, Paul Russo, Joel Sheinfeld, Madhu Mazumdar, William Tong, Farhang Rabbani, Machelle S Donat, Harry W Herr, Pramod Sogani, Dominique dePalma, Dean Bajorin> ;Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Aug 1 179 citations
Comparisons of nomograms and urologists' predictions in prostate cancer.
Phillip L. Ross, Claudia Gerigk, Mithat Gonen, Ofer Yossepowitch, Ilias Cagiannos, Pramod C. Sogani, Peter T. Scardino, Michael W. Kattan> ;Seminars in Urologic Oncology. 2002 May 1 268 citations
DOES EARLY CYSTECTOMY IMPROVE THE SURVIVAL OF PATIENTS WITH HIGH RISK SUPERFICIAL BLADDER TUMORS
Harry W. Herr, Pramod C. Sogani> ;The Journal of Urology. 2001 Oct 1 11 citations
INTRAVASCULAR CAPILLARY HEMANGIOMA PRESENTING AS A SOLID RENAL MASS
Gerald W. Hull, Elizabeth M. Genega, Pramod C. Sogani> ;The Journal of Urology. 1999 Sep 1 111 citations
CLINICAL STAGE I TESTIS CANCER: LONG-TERM OUTCOME OF PATIENTS ON SURVEILLANCE
Pramod C. Sogani, Michael Perrotti, Harry W. Herr, William R. Fair, Howard T. Thaler, George J. Bosl> ;The Journal of Urology. 1998 Mar 1 27 citations
Paternity in men with stage I testis tumors on surveillance.
Harry W. Herr, N Bar-Chama, Maryellen O’Sullivan, Pramod C. Sogani> ;Journal of Clinical Oncology. 1998 Feb 1 409 citations
The Treated Natural History of High Risk Superficial Bladder Cancer: 15-year Outcome
Michael S. Cookson, Harry W. Herr, Zuo-Feng Zhang, Scott M. Soloway, Pramod C. Sogani, William R. Fair> ;The Journal of Urology. 1997 Jul 1 63 citations
The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results**
William R. Fair, Michael S. Cookson, Nicholas Stroumbakis, David W. Cohen, Armen Aprikian, Yu Wang, Paul Russo, Scott M. Soloway, Pramod C. Sogani, Joel Sheinfeld, Har...> ;Urology. 1997 Mar 1 32 citations
Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prosta...
Michael S. Cookson, Pramod C. Sogani, Paul Russo, Joel Sheinfeld, Harry W. Herr, Guido Dalbagni, Victor E. Reuter, Colin B. Begg, William R. Fair> ;BJUI. 1997 Mar 1 217 citations
Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial.
Harry W. Herr, David M. Schwalb, Zuo-Feng Zhang, Pramod C. Sogani, William R. Fair, Willet F. Whitmore, Herbert F. Oettgen> ;Journal of Clinical Oncology. 1995 Jun 1 25 citations
EXPERIENCE WITH NEOADJUVANT DIETHYLSTILBOESTROL AND RADICAL PROSTATECTOMY IN PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER
Armen Aprikian, William R. Fair, Victor E. Reuter, Pramod C. Sogani, Harry W. Herr, Paul Russo, Joel Sheinfeld> ;BJUI. 1994 Nov 1 25 citations
Positive Urinary Cytology Following a Complete Response to Intravesical Bacillus Calmette-Guerin Therapy: Pattern of Recurrence
M. David Schwalb, Harry W. Herr, Pramod C. Sogani, Paul Russo, Joel Sheinfeld, William R. Fair> ;The Journal of Urology. 1994 Aug 1 59 citations
The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. The Memorial Sloan-Kettering Cancer Center experience.
Johannes Vieweg, Willet F. Whitmore, Harry W. Herr, Pramod C. Sogani, Paul Russo, Joel Sheinfeld, William R. Fair> ;Cancer. 1994 Jun 15 8 citations
Association of Primary Germ Cell Tumor of the Testis and Renal Cell Carcinoma
Bradley E. Davis, Pramod C. Sogani, Harry W. Herr> ;The Journal of Urology. 1993 Nov 1 Join now to see all Insurance Accepted
Aetna Choice POS II
Aetna HMO BCBS Blue Card PPO CIGNA HMO CIGNA Open Access CIGNA PPO Empire BCBS HMO Empire BCBS PPO First Health PPO GHI PPO
Great West PPO
Humana ChoiceCare Network PPO Multiplan PHCS PPO Multiplan PPO MVP Healthcare PPO QualCare HMO QualCare PPO United Healthcare - Direct Choice Plus POS United Healthcare - Direct Options PPO Please verify your coverage with the provider's office directly when scheduling an appointment